Plasma Processing Conditions Substantially Influence Circulating microRNA Biomarker Levels
Heather H. Cheng, Hye Son Yi, Yeon-Ju Kim et al. · PLoS ONE · 2013
Circulating, cell-free microRNAs (miRNAs) are promising candidate biomarkers, but optimal conditions for processing blood specimens for miRNA measurement remain to be established. Our previous work showed that the majority of plasma miRNAs are likely blood cell-derived. In the course of profiling lung cancer cases versus healthy controls, we observed a broad increase in circulating miRNA levels in cases compared to controls and that higher miRNA expression correlated with higher platelet and particle counts. We therefore hypothesized that the quantity of residual platelets and microparticles remaining after plasma processing might impact miRNA measurements. To systematically investigate this, we subjected matched plasma from healthy individuals to stepwise processing with differential centrifugation and 0.22 µm filtration and performed miRNA profiling. We found a major effect on circulating miRNAs, with the majority (72%) of detectable miRNAs substantially affected by processing alone. Specifically, 10% of miRNAs showed 4-30x variation, 46% showed 30-1,000x variation, and 15% showed >1,000x variation in expression solely from processing. This was predominantly due to platelet contamination, which persisted despite using standard laboratory protocols. Importantly, we show that platelet contamination in archived samples could largely be eliminated by additional centrifugation, even in frozen samples stored for six years. To minimize confounding effects in microRNA biomarker studies, additional steps to limit platelet contamination for circulating miRNA biomarker studies are necessary. We provide specific practical recommendations to help minimize confounding variation attributable to plasma processing and platelet contamination.
Cited by 311 works. doi:10.1371/journal.pone.0064795 Open-access PDF
Authors
- Heather H. Cheng
- Hye Son Yi
- Yeon-Ju Kim
- Evan M. Kroh
- Jason W. Chien
- Keith D. Eaton
- Marc T. Goodman
- Jonathan F. Tait
- Muneesh Tewari
- Colin C. Pritchard
References
- In silico prediction of protein-protein interactions in human macrophages
- Significance analysis of microarrays applied to the ionizing radiation response
- Circulating microRNAs as stable blood-based markers for cancer detection
- Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases
- Detection of elevated levels of tumour‐associated microRNAs in serum of patients with diffuse large B‐cell lymphoma
- Analysis of circulating microRNA biomarkers in plasma and serum using quantitative reverse transcription-PCR (qRT-PCR)
- MicroRNAs in body fluids—the mix of hormones and biomarkers
- Circulating microRNAs as Novel Minimally Invasive Biomarkers for Breast Cancer
- Blood Cell Origin of Circulating MicroRNAs: A Cautionary Note for Cancer Biomarker Studies
- Circulating microRNAs in plasma of patients with gastric cancers